Global Antibacterial Drugs Market 2017-2027

NEW YORK, May 18, 2017 /PRNewswire/ -- Report Details
The global antibacterial drugs market is expected to grow at a CAGR of 1.3% in the first half of the forecast period and a CAGR of 3.1% in the second half of the forecast period. The market is estimated at $41.76bn in 2016 and $44.54bn in 2021.


Read the full report: http://www.reportlinker.com/p04890879/Global-Antibacterial-Drugs-Market.html



How this report will benefit you
- Read on to discover how you can exploit the future business opportunities emerging in this sector.
- In this brand new 304-page report you will receive 124 tables and 97 figures – all unavailable elsewhere.
- The 304-page report provides clear detailed insight into the global antibacterial drugs market. Discover the key drivers and challenges affecting the market.
- By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
• Global Antibacterial Drugs Market forecasts from 2017-2027

• Revenue forecasts for the 6 leading submarkets from 2017-2027:
- Cephalosporins
- Penicillins
- Fluoroquinolones
- Macrolides
- Carbapenems
- Others

• Revenue forecasts for the 43 leading marketed antibacterial drugs from 2017-2027:
- Cephalosporins: Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam
- Penicillins: Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic amoxicllin-clavulanic acid, Amoxil
- Fluoroquinolones: Avelox, Cravit, Vigamox, Ciprodex, Cipro/Ciprobay, Geninax, Defafloxacin
- Macrolides: Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin
- Carbapenems: Invanz, Merrem/Meropen, Primaxin, Doribax
- Other antibacterial drugs: Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin

• Revenue forecasts for the leading developed and emerging national and regional markets. Markets forecasted in this report are the following:
- The US
- The EU: France, Germany, Italy, Spain, the UK, and others
- Japan
- The BRIC countries: Brazil, Russia, India, China
- South Korea
- The Rest of the World

• Analysis of the strengths, weaknesses as well as the opportunities and threats of the antibacterial drugs industry and market

• Coverage of antibacterial drug candidates in the R&D pipeline. Discussions of research and development – see progress in this industry, finding technological, clinical and commercial outlooks and opportunities

Visiongain's study is intended for anyone requiring commercial analyses for the Global Antibacterial Drugs Market. You find data, trends and predictions.

Buy our report today Global Antibacterial Drugs Market 2017-2027: Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others.

visiongain is a trading partner with the US Federal Government
Read the full report: http://www.reportlinker.com/p04890879/Global-Antibacterial-Drugs-Market.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-antibacterial-drugs-market-2017-2027-300460298.html

SOURCE Reportlinker